Henry W. Lim

2 months ago | jamanetwork.com | Joel M. Gelfand |April W. Armstrong |Henry W. Lim |Steven Feldman

Errors in Abstract, Results, and Table 1 Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis Joel M. Gelfand, MD; April W. Armstrong, MD; Henry W. Lim, MD; Steven R. Feldman, MD, PhD; Sandra M. Johnson, MD; W. C. Cole Claiborne, MD; Robert E. Kalb, MD; Jeannette Jakus, MD; Aaron R. Mangold, MD; R. Hal Flowers, MD; Tina Bhutani, MD; John R. Durkin, MD; Jerry Bagel, MD; Scott Fretzin, MD; Michael P.

Jun 5, 2024 | dermatologytimes.com | Emma Andrus |Henry W. Lim

The Global Hidradenitis Suppurativa Atlas (GHiSA), has released an in-depth report on hidradenitis suppurativa (HS). This comprehensive document, developed with the backing of the International League of Dermatological Societies (ILDS), delves into various aspects of HS, from diagnosis to its impact on patients' lives and the available treatment options. The report also sheds light on the significant gaps, barriers, and challenges that exist in the understanding of HS.

Mar 18, 2024 | dermatologytimes.com | Henry W. Lim |Heidi Anne Duerr

The poster “Long-Term Adverse Event Risks of Systemic Janus Kinase (JAK) Inhibitors versus Traditional Immunomodulators” won third place at the 2024 American Academy of Dermatology Annual Meeting.1Because JAK inhibitors have proven effective in treating atopic dermatitis and alopecia areata and has shown promise for other dermatological disorders, researchers and clinicians remain concerned about the US Food and Drug Administration’s black box warning regarding their long-term use.